Lithium Carbonate
Back to searchMolecule Structure
Scientific Name
Lithium Carbonate
Description of the Drug
Lithium carbonate is a medication used to treat manic episodes of bipolar disorder.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB14509
http://www.drugbank.ca/drugs/DB14509
Brand Name(s)
Camcolit 250, Camcolit 400, Eskalith, Eskalith cr, Liskonum, Lithane, Lithium carbonate, Lithobid, Lithonate, Lithotabs, Phasal
Company Owner(s)
Heritage Pharma Labs Inc, Sun Pharmaceutical Industries Inc, Watson Laboratories Inc, Noven Therapeutics Llc, Jds Pharmaceuticals Llc, Mylan Pharmaceuticals Inc, Able Laboratories Inc, Unique Pharmaceutical Laboratories A Division Of J.B. Chemicals And Pharmaceuticals Ltd, Ani Pharmaceuticals Inc, Glenmark Generics Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Glycogen synthase kinase-3 | PROTEIN FAMILY | INHIBITOR | CHEMBL2095188 |
| Inositol-1(or 4)-monophosphatase 1 | SINGLE PROTEIN | INHIBITOR | CHEMBL1786 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL25389 | |
| DrugBank | DB14509 | |
| PubChem: Thomson Pharma | 15146288 | |
| PubChem | 516884 | 11125 |
| Nikkaji | J425A | |
| EPA CompTox Dashboard | DTXSID1023784 | |
| Brenda | 172057 | |
| ChemicalBook | CB5852228 | |
| rxnorm | LITHIUM CARBONATE | LITHOBID |
| PubChem: Drugs of the Future | 24714729 | |
| KEGG Ligand | C07964 | |
| ChEBI | 6504 |
